No article text was recorded for this version.
phenotypic marker loss
Version 2 of 218 papers31 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Immunolipid magnetic bead-based circulating tumor cell sorting: a novel approach for pathological staging of colorectal cancer
- Blog: Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer
- Blog: Isolation and characterization of circulating tumor cells in prostate cancer
- Blog: Integrative Analysis and Machine Learning Based Characterization of Single Circulating Tumor Cells
- Blog: Enrichment of Hyaluronic Acid Binding Tumor Cells by Modulation of Selective Adhesion on Microgel Surfaces
- Blog: An Observational Study of Circulating Tumor Cells and 18F-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
- Blog: A case of malignant calcifying epithelial odontogenic tumor.
- Blog: New advances in circulating tumor cell‑mediated metastasis of breast cancer (Review)
- Blog: Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin
- Blog: Expression patterns of MRP2 in circulating tumor cells of breast cancer: a single-institution study
- Blog: Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
- Blog: Development and clinical validation of a microfluidic-based platform for CTC enrichment and downstream molecular analysis
- Blog: Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
- Blog: Longitudinal tracking of circulating rare events in the liquid biopsy of stage III–IV non-small cell lung cancer patients
- Blog: Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model
- Blog: Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
- Blog: DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum—Implications for the Choice of Circulating Tumour DNA Methylation Markers
- Blog: Molecular characterization of breast cancer CTCs associated with brain metastasis
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_phenotypic_marker_loss_1e820292,
title = {phenotypic marker loss},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/phenotypic-marker-loss/rdr_1e820292850045298199f35186d437c2},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 2, frozen text):
@misc{lacuna_phenotypic_marker_loss_1e820292_v2,
title = {phenotypic marker loss},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/phenotypic-marker-loss/rdr_1e820292850045298199f35186d437c2/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-20},
}